CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
56
CMA Quote, Financials, Valuation and Earnings
Last price:
$54.68
Seasonality move
:
3.3%
Day range:
$54.63 - $55.44
52-week range:
$45.32 - $73.45
Dividend yield:
5.18%
P/E ratio:
10.36x
P/S ratio:
2.23x
P/B ratio:
1.08x
Volume:
1.6M
Avg. volume:
2.1M
1-year change:
1.69%
Market cap:
$7.2B
Revenue:
$3.2B
EPS (TTM):
$5.29
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3B | $3.5B | $3.6B | $3.2B | |
| Revenue Growth (YoY) | -12.89% | 1.89% | 19.11% | 1.64% | -9.69% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | |
| Other Inc / (Exp) | $85M | -- | $8M | -$42M | -$11M | |
| Operating Expenses | $1.1B | $1.2B | $1.3B | $1.3B | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $621M | $1.5B | $1.5B | $1.1B | $888M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $124M | $322M | $325M | $263M | $190M | |
| Net Income to Company | $497M | $1.2B | $1.2B | $881M | $698M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $497M | $1.2B | $1.2B | $881M | $698M | |
| Basic EPS (Cont. Ops) | $3.45 | $8.45 | $8.56 | $6.47 | $5.06 | |
| Diluted EPS (Cont. Ops) | $3.43 | $8.35 | $8.47 | $6.44 | $5.02 | |
| Weighted Average Basic Share | $139M | $135M | $131M | $132M | $133M | |
| Weighted Average Diluted Share | $140M | $137M | $133M | $133M | $134M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $803M | $1.5B | $1.7B | $2.8B | $2.6B | |
| Revenue (Reported) | $2.9B | $3B | $3.5B | $3.6B | $3.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $803M | $1.5B | $1.7B | $2.8B | $2.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $713M | $700M | $990M | $784M | $829M | |
| Revenue Growth (YoY) | -4.93% | -1.82% | 41.43% | -20.81% | 5.74% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $294M | $304M | $347M | $376M | $390M | |
| Other Inc / (Exp) | $30M | -- | $8M | -$25M | $7M | |
| Operating Expenses | $294M | $304M | $347M | $360M | $390M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $448M | $238M | $409M | $167M | $225M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $98M | $49M | $85M | $29M | $53M | |
| Net Income to Company | $350M | $189M | $324M | $138M | $172M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $350M | $189M | $324M | $138M | $172M | |
| Basic EPS (Cont. Ops) | $2.46 | $1.39 | $2.41 | $0.99 | $1.26 | |
| Diluted EPS (Cont. Ops) | $2.43 | $1.37 | $2.39 | $0.98 | $1.25 | |
| Weighted Average Basic Share | $140M | $131M | $131M | $132M | $132M | |
| Weighted Average Diluted Share | $141M | $133M | $132M | $133M | $133M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $464M | $251M | $650M | $638M | $574M | |
| Revenue (Reported) | $713M | $700M | $990M | $784M | $829M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $464M | $251M | $650M | $638M | $574M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3B | $3.8B | $3.4B | $3.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | |
| Other Inc / (Exp) | $96M | -$48M | $16M | -$75M | $21M | |
| Operating Expenses | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.1B | $1.3B | $1.6B | $902M | $946M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $241M | $273M | $361M | $207M | $214M | |
| Net Income to Company | $906M | $1B | $1.3B | $695M | $732M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $906M | $1B | $1.3B | $695M | $732M | |
| Basic EPS (Cont. Ops) | $6.30 | $7.35 | $9.59 | $5.06 | $5.33 | |
| Diluted EPS (Cont. Ops) | $6.24 | $7.25 | $9.49 | $5.03 | $5.29 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.2B | $1.3B | $2.1B | $2.8B | $2.6B | |
| Revenue (Reported) | $2.9B | $3B | $3.8B | $3.4B | $3.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.2B | $1.3B | $2.1B | $2.8B | $2.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $713M | $700M | $990M | $784M | $829M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $294M | $304M | $347M | $376M | $390M | |
| Other Inc / (Exp) | $30M | -- | $8M | -$25M | $7M | |
| Operating Expenses | $294M | $304M | $347M | $360M | $390M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $448M | $238M | $409M | $167M | $225M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $98M | $49M | $85M | $29M | $53M | |
| Net Income to Company | $350M | $189M | $324M | $138M | $172M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $350M | $189M | $324M | $138M | $172M | |
| Basic EPS (Cont. Ops) | $2.46 | $1.39 | $2.41 | $0.99 | $1.26 | |
| Diluted EPS (Cont. Ops) | $2.43 | $1.37 | $2.39 | $0.98 | $1.25 | |
| Weighted Average Basic Share | $140M | $131M | $131M | $132M | $132M | |
| Weighted Average Diluted Share | $141M | $133M | $132M | $133M | $133M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $464M | $251M | $650M | $638M | $574M | |
| Revenue (Reported) | $713M | $700M | $990M | $784M | $829M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $464M | $251M | $650M | $638M | $574M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.8B | $22.7B | $6.3B | $9.5B | $6.8B | |
| Short Term Investments | $15.2B | $17.2B | $19.2B | $17.3B | $7.4B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $31.6B | $40.5B | $26.2B | $27.6B | $14.9B | |
| Property Plant And Equipment | $459M | $454M | $400M | $445M | $473M | |
| Long-Term Investments | $15.2B | $17.2B | $19.2B | $17.3B | $7.4B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $88.1B | $94.6B | $85.4B | $85.8B | $79.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $3.2B | $3.6B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $905M | $877M | $4.1B | $3.6B | -- | |
| Long-Term Debt | $4.8B | $1.9B | $2.2B | $6.2B | $6.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $80.1B | $86.7B | $80.2B | $79.4B | $72.8B | |
| Common Stock | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $7.7B | $7.5B | $4.8B | $6B | $6.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.1B | $7.9B | $5.2B | $6.4B | $6.5B | |
| Total Liabilities and Equity | $88.1B | $94.6B | $85.4B | $85.8B | $79.3B | |
| Cash and Short Terms | $31B | $39.9B | $25.5B | $26.8B | $14.2B | |
| Total Debt | $5.7B | $2.8B | $6.2B | $9.8B | $6.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $14.9B | $13.6B | $10.7B | $5.1B | $5.8B | |
| Short Term Investments | $15.8B | $19B | $850M | $8.8B | $7.8B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $31.2B | $33.2B | $12.4B | $14.7B | $14.3B | |
| Property Plant And Equipment | $456M | $444M | $399M | $462M | $447M | |
| Long-Term Investments | $15.8B | $19B | $18.6B | $8.8B | $7.8B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $86.3B | $89.2B | $91.1B | $79.4B | $77.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $11B | -- | $1.2B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $898M | $857M | $11.9B | -- | $1.2B | |
| Long-Term Debt | $2B | $1.8B | $6.2B | $7.1B | $5.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $78.1B | $82.1B | $85.1B | $73.4B | $70.6B | |
| Common Stock | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.2B | $7B | $6B | $6.1B | $7.1B | |
| Total Liabilities and Equity | $86.3B | $89.2B | $91.1B | $79.4B | $77.6B | |
| Cash and Short Terms | $30.6B | $32.5B | $11.6B | $13.9B | $13.6B | |
| Total Debt | $2.9B | $2.7B | $18.1B | $7.1B | $7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $497M | $1.2B | $1.2B | $881M | $698M | |
| Depreciation & Amoritzation | $108M | $99M | $92M | $87M | $96M | |
| Stock-Based Compensation | $24M | $41M | $60M | $52M | $54M | |
| Change in Accounts Receivable | $25M | $13M | -$152M | -$65M | $83M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $928M | $634M | $638M | $1.3B | $601M | |
| Capital Expenditures | $79M | $70M | $82M | $153M | $153M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.6B | $1.7B | -$10B | $3.5B | $3.3B | |
| Dividends Paid (Ex Special Dividend) | -$383M | -$392M | -$376M | -$394M | -$400M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $500M | $4B | $1B | |
| Long-Term Debt Repaid | -$1.7B | -$2.8B | -- | -$850M | -$500M | |
| Repurchase of Common Stock | -$199M | -$729M | -$36M | -- | -$100M | |
| Other Financing Activities | -$1M | $4M | -$9M | -$19M | -$14M | |
| Cash From Financing | $13.6B | $4.6B | -$7.1B | -$1.5B | -$6.6B | |
| Beginning Cash (CF) | $5.8B | $15.8B | $22.7B | $6.3B | $9.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.9B | $6.9B | -$16.4B | $3.2B | -$2.7B | |
| Ending Cash (CF) | $15.8B | $22.7B | $6.3B | $9.5B | $6.8B | |
| Levered Free Cash Flow | $849M | $564M | $556M | $1.1B | $448M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $350M | $189M | $324M | $138M | $172M | |
| Depreciation & Amoritzation | $25M | $23M | $20M | $22M | $25M | |
| Stock-Based Compensation | $22M | $28M | $28M | $27M | $27M | |
| Change in Accounts Receivable | -$5M | -$1M | -$34M | $9M | $13M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $159M | -$710M | $462M | -$205M | $273M | |
| Capital Expenditures | $18M | $17M | $21M | $40M | $7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1B | -$3.2B | -$1B | $1.7B | $913M | |
| Dividends Paid (Ex Special Dividend) | -$101M | -$95M | -$94M | -$98M | -$99M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $4B | $1B | -- | |
| Long-Term Debt Repaid | -$2.8B | -- | -- | -- | -$1B | |
| Repurchase of Common Stock | -$8M | -$39M | -$15M | -- | -$50M | |
| Other Financing Activities | $12M | -$2M | -- | -$12M | -$14M | |
| Cash From Financing | -$2.1B | -$5.2B | $5B | -$5.9B | -$2.2B | |
| Beginning Cash (CF) | $15.8B | $22.7B | $6.3B | $9.5B | $6.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$896M | -$9.1B | $4.5B | -$4.4B | -$1B | |
| Ending Cash (CF) | $14.9B | $13.6B | $10.7B | $5.1B | $5.8B | |
| Levered Free Cash Flow | $141M | -$727M | $441M | -$245M | $266M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $906M | $1B | $1.3B | $695M | $732M | |
| Depreciation & Amoritzation | $107M | $97M | $89M | $89M | $99M | |
| Stock-Based Compensation | $38M | $47M | $60M | $51M | $54M | |
| Change in Accounts Receivable | $12M | $17M | -$185M | -$22M | $87M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $388M | -$235M | $1.8B | $584M | $1.1B | |
| Capital Expenditures | $82M | $69M | $86M | $172M | $120M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$60M | -$2.5B | -$7.8B | $6.2B | $2.4B | |
| Dividends Paid (Ex Special Dividend) | -$389M | -$386M | -$375M | -$398M | -$401M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $4.5B | $1B | -- | |
| Long-Term Debt Repaid | -$4.5B | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$8M | -$760M | -$12M | $15M | -$150M | |
| Other Financing Activities | -- | -$10M | -- | -- | -$16M | |
| Cash From Financing | $9.7B | $1.4B | $3.1B | -$12.4B | -$2.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10B | -$1.3B | -$2.8B | -$5.6B | $657M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $306M | -$304M | $1.7B | $412M | $959M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $350M | $189M | $324M | $138M | $172M | |
| Depreciation & Amoritzation | $25M | $23M | $20M | $22M | $25M | |
| Stock-Based Compensation | $22M | $28M | $28M | $27M | $27M | |
| Change in Accounts Receivable | -$5M | -$1M | -$34M | $9M | $13M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $159M | -$710M | $462M | -$205M | $273M | |
| Capital Expenditures | $18M | $17M | $21M | $40M | $7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1B | -$3.2B | -$1B | $1.7B | $913M | |
| Dividends Paid (Ex Special Dividend) | -$101M | -$95M | -$94M | -$98M | -$99M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $4B | $1B | -- | |
| Long-Term Debt Repaid | -$2.8B | -- | -- | -- | -$1B | |
| Repurchase of Common Stock | -$8M | -$39M | -$15M | -- | -$50M | |
| Other Financing Activities | $12M | -$2M | -- | -$12M | -$14M | |
| Cash From Financing | -$2.1B | -$5.2B | $5B | -$5.9B | -$2.2B | |
| Beginning Cash (CF) | $15.8B | $22.7B | $6.3B | $9.5B | $6.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$896M | -$9.1B | $4.5B | -$4.4B | -$1B | |
| Ending Cash (CF) | $14.9B | $13.6B | $10.7B | $5.1B | $5.8B | |
| Levered Free Cash Flow | $141M | -$727M | $441M | -$245M | $266M | |
Get CMA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CMA
Sector
P/E ratio
10.36x
11.34x
PEG ratio
2.00x
0.38x
P/B ratio
1.08x
1.04x
Price / LTM sales
2.23x
2.46x
Growth Metrics
CMA
Sector
Revenue growth
5.74%
5.74%
Earnings growth
27.55%
6.25%
Revenue (5-year growth)
-0.6%
5.15%
Earnings forecast
$1.13
$0.57
Profitability
CMA
Sector
Profitability FY 2025
--
$150.9M
Return on invested capital
5.3%
5.45%
Return on assets
0.93%
0.98%
Return on equity
11.03%
9.37%
Earnings Date
Last Earnings Date
Apr
21
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Jul
21
Balance Sheet
CMA
Sector
Total cash
$13.6B
$523.2M
Short term investments
$7.4B
$233.8M
Total assets
$79.3B
$4.1B
Long term debt
$7B
$299.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
